Publisher
Springer Science and Business Media LLC
Reference85 articles.
1. Mills, R. J., Parker, B. L., Quaife-Ryan, G. A., Voges, H. K., Needham, E. J., Bornot, A., Ding, M., Andersson, H., Polla, M., & Elliott, D. A. (2019). Drug screening in human PSC-cardiac organoids identifies pro-proliferative compounds acting via the mevalonate pathway. Cell stem cell, 24(6), 895–907. e6.
2. Inoue, H., Nagata, N., Kurokawa, H., & Yamanaka, S. (2014). iPS cells: A game changer for future medicine. The EMBO Journal, 33(5), 409–417.
3. Ghaedi, M., Le, A. V., Hatachi, G., Beloiartsev, A., Rocco, K., Sivarapatna, A., Mendez, J. J., Baevova, P., Dyal, R. N., & Leiby, K. L. (2018). Bioengineered lungs generated from human i PSC s-derived epithelial cells on native extracellular matrix. Journal of Tissue Engineering and Regenerative Medicine, 12(3), e1623–e1635.
4. Khandany, B., Heidari, M. M., & Khatami, M. (2019). Induced pluripotent stem cells (iPSCs) based approaches for hematopoietic cancer therapy. Iranian Journal of Pediatric Hematology and Oncology, 9(2), 117–130.
5. Fuchs, E., & Segre, J. A. (2000). Stem cells: A new lease on life. Cell, 100(1), 143–155.